Podcast Episode
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Listen to expert insights from Joseph J. Eron, Jr., MD, on exciting data about investigational agents (dapivirine ring, islatravir, lenacapavir, broadly neutralizing antibodies) for next-generation HIV prevention.
Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Clinical Care Options (CCO) expert audio: Dr. Colleen Kelley provides key insights on long-acting HIV pre-exposure prophylaxis strategies in late stages of development
Colleen Kelley, MD, MPH
Released: September 16, 2021
Clinical Care Options (CCO) faculty Dr David Malebranche’s expert commentary on racial disparities in HIV care and strategies for improving patient engagement
David Malebranche, MD, MPH
Released: September 15, 2021
Clinical Care Options’ (CCO) podcast with Drs. Daar and Swaminathan on key data following IAS 2021: CAB plus RPV, lenacapavir, islatravir, BPaL for MDR-TB
Eric S. Daar, MD
Shobha Swaminathan, MD
Released: September 14, 2021
Download CCO slides reviewing clinically relevant new data reported at IAS 2021 on a wide range of ART management topics.
Joseph J. Eron, Jr., MD
Princy N. Kumar, MD, FIDSA, MACP
Daniel R. Kuritzkes, MD
Released: September 13, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.